White Plains, NY, United States of America

Gangadhar Dhulipala

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gangadhar Dhulipala. Retrieved from https://idiyas.com/inventor/gangadhar-dhulipala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gangadhar Dhulipala

Gangadhar Dhulipala is an accomplished inventor based in Tarrytown, NY (US). He is currently associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. Despite having no patents to his name, Dhulipala's contributions to the field of pharmaceuticals are noteworthy.

Latest Patents

As of now, Gangadhar Dhulipala holds 1 patents. However, his work in the industry reflects a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Dhulipala has been involved in various projects that focus on the development of therapeutic solutions. His role at Regeneron Pharmaceuticals, Inc. has allowed him to collaborate with some of the brightest minds in the industry, contributing to significant advancements in biotechnology.

Collaborations

One of his notable coworkers is Kun Lu, with whom he has shared insights and expertise in their respective fields. Their collaboration exemplifies the spirit of teamwork that drives innovation in the pharmaceutical industry.

Conclusion

In summary, Gangadhar Dhulipala is a dedicated inventor whose work at Regeneron Pharmaceuticals, Inc. highlights his commitment to advancing healthcare solutions. His journey in the field continues to inspire those around him.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…